Radical prostatectomy in T4 prostate cancer after inductive androgen deprivation: results of a single-institution series with long-term follow-up

被引:21
|
作者
Hajili, Turkan [1 ]
Ohlmann, Carsten H. [1 ]
Linxweiler, Johannes [1 ]
Niklas, Christina [1 ]
Janssen, Martin [1 ]
Siemer, Stefan [1 ]
Stoeckle, Michael [1 ]
Saar, Matthias [1 ]
机构
[1] Saarland Univ, Dept Urol & Pediat Urol, D-66421 Homburg, Germany
关键词
inductive androgen deprivation; inoperable high-risk prostate cancer; prostate-specific antigen nadir; radical prostatectomy; #pcsm; #ProstateCancer; NEOADJUVANT HORMONAL-THERAPY; HIGH-RISK; PHASE-II; MEN; SURVIVAL; ADENOCARCINOMA;
D O I
10.1111/bju.14393
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo determine the outcomes of complete surgical resection of T4 prostate cancer after inductive androgen-deprivation therapy (ADT), as inductive ADT and subsequent radical prostatectomy (RP) is not recommended by any guideline yet. Patients and MethodsA monocentric RP database was queried for patients initially diagnosed with T4 prostate cancer, considered primarily as inoperable because of a fixed mass defined by rectal examination in combination with high PSA level and/or large foci of biopsy confirmed undifferentiated prostate cancer. Treatment consisted of primary ADT until PSA nadir with consecutive RP. Patients underwent retropubic RP (RRP) or robot-assisted laparoscopic RP (RALP) after inductive ADT until achievement of the PSA nadir, which is in general reached after 6-7months. The intraoperative course and complications were analysed. Finally, Kaplan-Meier estimates were calculated for overall survival (OS) and prostate cancer-specific survival (PCSS). ResultsWe retrospectively identified 116 patients treated between 2000 and 2014. At diagnosis, the median (range) PSA level was 37.6 (2.44-284) ng/mL. The preoperative median (range) PSA after inductive ADT was 0.73 (0.01-34) ng/mL. Thereafter, patients underwent RRP or, since 2006, RALP. The median (95% confidence interval) OS was 156 (118.9-193.1) months. The PCSS at 150months was 82%. ConclusionsSurgical therapy of primarily inoperable prostate cancer is feasible and safe after inductive ADT. The OS of this cohort seems comparable with results described for patients with primary operable high-risk prostate cancer.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [31] Robotic Radical Prostatectomy for Patients with Locally Advanced Prostate Cancer Is Feasible: Results of a Single-Institution Study
    Ham, Won Sik
    Park, Sung Yul
    Rha, Koon Ho
    Kim, Won Tae
    Choi, Young Deuk
    JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES, 2009, 19 (03): : 329 - 332
  • [32] Risk Stratification of pN plus Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup
    Moschini, Marco
    Sharma, Vidit
    Zattoni, Fabio
    Boorjian, Stephen A.
    Frank, Igor
    Gettman, Matthew T.
    Thompson, R. Houston
    Tollefson, Matthew K.
    Kwon, Eugene D.
    Karnes, R. Jeffrey
    JOURNAL OF UROLOGY, 2016, 195 (06): : 1773 - 1778
  • [33] Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer: Long-term follow-up of the SPCG-6 study
    Thomsen, Frederik B.
    Brasso, Klaus
    Christensen, Ib J.
    Johansson, Jan-Erik
    Angelsen, Anders
    Tammela, Teuvo L. J.
    Iversen, Peter
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) : 1283 - 1292
  • [34] Prostate cancer-related anxiety in long-term survivors after radical prostatectomy
    Valentin H. Meissner
    Kathleen Herkommer
    Birgitt Marten-Mittag
    Jürgen E. Gschwend
    Andreas Dinkel
    Journal of Cancer Survivorship, 2017, 11 : 800 - 807
  • [35] Zonal origin of prostate cancer: comparison of long-term outcomes after radical prostatectomy
    Luttrell, Laura
    Li, Jian
    Cohen, Ronald J. J.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (08) : 1951 - 1956
  • [36] Long-term impact of positive surgical margins on biochemical recurrence after radical prostatectomy: Ten years of follow-up
    Rouanne, Mathieu
    Rode, Julie
    Campeggi, Alexandre
    Allory, Yves
    Vordos, Dimitri
    Hoznek, Andras
    Abbou, Claude-Clement
    De la Taille, Alexandre
    Salomon, Laurent
    SCANDINAVIAN JOURNAL OF UROLOGY, 2014, 48 (02) : 131 - 137
  • [37] Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer
    Siddiqui, Sameer A.
    Boorjian, Stephen A.
    Blute, Michael L.
    Rangel, Laureano J.
    Bergstralh, Eric J.
    Karnes, Robert Jeffrey
    Frank, Igor
    BJU INTERNATIONAL, 2011, 107 (03) : 383 - 388
  • [38] Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series
    Gandaglia, Giorgio
    Fossati, Nicola
    Karnes, R. Jeffrey
    Boorjian, Stephen A.
    Colicchia, Michele
    Bossi, Alberto
    Seisen, Thomas
    Cozzarini, Cesare
    Di Muzio, Nadia
    Chiorda, Barbara Noris
    Zaffuto, Emanuele
    Wiegel, Thomas
    Shariat, Shahrokh F.
    Goldner, Gregor
    Joniau, Steven
    Battaglia, Antonino
    Haustermans, Karin
    De Meerleer, Gert
    Fonteyne, Valerie
    Ost, Piet
    Van Poppel, Hendrick
    Montorsi, Francesco
    Briganti, Alberto
    EUROPEAN UROLOGY, 2018, 73 (04) : 512 - 518
  • [39] Hormonal response recovery after long-term androgen deprivation therapy in patients with prostate cancer
    Planas, Jacques
    Celma, Ana
    Placer, Jose
    Cuadras, Merce
    Regis, Lucas
    Gasanz, Carlos
    Trilla, Enrique
    Salvador, Carlos
    Lorente, David
    Morote, Juan
    SCANDINAVIAN JOURNAL OF UROLOGY, 2016, 50 (06) : 425 - 428
  • [40] Role of Adjuvant Chemoradiotherapy for Duodenal Cancer: An Updated Analysis of Long-Term Follow-Up from Single Institution
    Jang, Bum-Sup
    Park, Hae Jin
    Kim, Kyubo
    Jang, Jin-Young
    Kim, Sun Whe
    Oh, Do-Youn
    Chie, Eui Kyu
    WORLD JOURNAL OF SURGERY, 2018, 42 (10) : 3294 - 3301